Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1997 1
1998 2
1999 2
2000 3
2001 1
2002 5
2003 1
2004 3
2005 4
2006 10
2007 8
2008 15
2009 20
2010 16
2011 8
2012 11
2013 6
2014 9
2015 12
2016 9
2017 12
2018 10
2019 5
2020 13
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

170 results
Results by year
Filters applied: . Clear all
Page 1
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria.
Rinke A, Maintz C, Müller L, Weber MM, Lahner H, Pavel M, Saeger W, Houchard A, Ungewiss H, Petersenn S. Rinke A, et al. Among authors: petersenn s. Exp Clin Endocrinol Diabetes. 2021 Jul;129(7):500-509. doi: 10.1055/a-1342-2755. Epub 2021 Jul 22. Exp Clin Endocrinol Diabetes. 2021. PMID: 34293802 Free PMC article.
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Christ-Crain M, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M; “Pituitary Society Delphi Collaborative Group”. Tritos NA, et al. Pituitary. 2021 Jul 20:1-10. doi: 10.1007/s11102-021-01170-3. Online ahead of print. Pituitary. 2021. PMID: 34283370 Free PMC article.
Medical Therapy of Aggressive Pituitary Tumors.
Petersenn S. Petersenn S. Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):186-193. doi: 10.1055/a-1331-6939. Epub 2021 Mar 9. Exp Clin Endocrinol Diabetes. 2021. PMID: 33690871
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland.
Störmann S, Schopohl J, Bullmann C, Terkamp C, Christ-Crain M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Stalla G, Houchard A, Helbig D, Petersenn S. Störmann S, et al. Among authors: petersenn s. Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):224-233. doi: 10.1055/a-1247-4713. Epub 2020 Dec 7. Exp Clin Endocrinol Diabetes. 2021. PMID: 33285601
Bevacizumab in Aggressive Pituitary Adenomas - Experience with 3 Patients.
Osterhage K, Rotermund R, Droste M, Dierlamm J, Saeger W, Petersenn S, Aberle J, Flitsch J. Osterhage K, et al. Among authors: petersenn s. Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):178-185. doi: 10.1055/a-1260-3975. Epub 2020 Dec 7. Exp Clin Endocrinol Diabetes. 2021. PMID: 33285600
Multidisciplinary management of acromegaly: A consensus.
Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S. Giustina A, et al. Among authors: petersenn s. Rev Endocr Metab Disord. 2020 Dec;21(4):667-678. doi: 10.1007/s11154-020-09588-z. Epub 2020 Sep 10. Rev Endocr Metab Disord. 2020. PMID: 32914330 Free PMC article. Review.
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study.
Lacroix A, Bronstein MD, Schopohl J, Delibasi T, Salvatori R, Li Y, Barkan A, Suzaki N, Tauchmanova L, Ortmann CE, Ravichandran S, Petersenn S, Pivonello R. Lacroix A, et al. Among authors: petersenn s. J Endocrinol Invest. 2020 Nov;43(11):1613-1622. doi: 10.1007/s40618-020-01246-0. Epub 2020 May 8. J Endocrinol Invest. 2020. PMID: 32385851 Clinical Trial.
[Hypoparathyroidism - un underestimated problem?].
Petersenn S, Bojunga J, Brabant G, Etzrodt-Walter G, Finke R, Scharla S, Stamm B, Weber MM, Wicke C, Siggelkow H. Petersenn S, et al. MMW Fortschr Med. 2019 Dec;161(Suppl 7):12-20. doi: 10.1007/s15006-019-1174-4. MMW Fortschr Med. 2019. PMID: 31828671 Review. German.
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey.
Elbelt U, Schlaffer SM, Buchfelder M, Knappe UJ, Vila G, Micko A, Deutschbein T, Unger N, Lammert A, Topuzoglu-Müller T, Bojunga J, Droste M, Johanssen S, Kolenda H, Ritzel K, Buslei R, Strasburger CJ, Petersenn S, Honegger J. Elbelt U, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz211. doi: 10.1210/clinem/dgz211. J Clin Endocrinol Metab. 2020. PMID: 31746334
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.
Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Ioachimescu A, Katznelson L, Kelestimur F, Kopchick J, Krsek M, Lamberts S, Losa M, Luger A, Maffei P, Marazuela M, Mazziotti G, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn S, Puig-Domingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, van der Lely AJ, Wass J, Zatelli MC, Melmed S. Giustina A, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgz096. doi: 10.1210/clinem/dgz096. J Clin Endocrinol Metab. 2020. PMID: 31606735 Free article.
Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma.
Mende KC, Kellner T, Petersenn S, Honegger J, Evangelista-Zamora R, Droste M, Stalla G, Deutschbein T, Wang Y, Moskopp D, Knappe U, Schilbach K, Flitsch J. Mende KC, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2020 Jan 1;105(1):dgz043. doi: 10.1210/clinem/dgz043. J Clin Endocrinol Metab. 2020. PMID: 31589293
Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study.
Fleseriu M, Petersenn S, Biller BMK, Kadioglu P, De Block C, T'Sjoen G, Vantyghem MC, Tauchmanova L, Wojna J, Roughton M, Lacroix A, Newell-Price J. Fleseriu M, et al. Among authors: petersenn s. Clin Endocrinol (Oxf). 2019 Dec;91(6):776-785. doi: 10.1111/cen.14081. Epub 2019 Oct 1. Clin Endocrinol (Oxf). 2019. PMID: 31465533 Free PMC article. Clinical Trial.
Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?
Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Schopohl J, Stalla G. Petersenn S, et al. Geburtshilfe Frauenheilkd. 2019 Apr;79(4):365-374. doi: 10.1055/a-0794-7587. Epub 2019 Mar 6. Geburtshilfe Frauenheilkd. 2019. PMID: 31000881 Free PMC article.
Black swans - neuroendocrine tumors of rare locations.
Koch CA, Petersenn S. Koch CA, et al. Among authors: petersenn s. Rev Endocr Metab Disord. 2018 Jun;19(2):111-121. doi: 10.1007/s11154-018-9473-0. Rev Endocr Metab Disord. 2018. PMID: 30341705
Aggressive pituitary tumours and carcinomas: two sides of the same coin?
Trouillas J, Burman P, McCormack A, Petersenn S, Popovic V, Dekkers O, Raverot G. Trouillas J, et al. Among authors: petersenn s. Eur J Endocrinol. 2018 Jun;178(6):C7-C9. doi: 10.1530/EJE-18-0250. Epub 2018 Mar 27. Eur J Endocrinol. 2018. PMID: 29588294 Review.
Pituitary disease management during pregnancy: an overview.
Petersenn S. Petersenn S. Minerva Endocrinol. 2018 Dec;43(4):420-422. doi: 10.23736/S0391-1977.18.02835-3. Epub 2018 Mar 15. Minerva Endocrinol. 2018. PMID: 29546742 Free article. No abstract available.
Editorial : Neuroendocrine neoplasms.
Koch CA, Petersenn S. Koch CA, et al. Among authors: petersenn s. Rev Endocr Metab Disord. 2017 Dec;18(4):379-380. doi: 10.1007/s11154-018-9441-8. Rev Endocr Metab Disord. 2017. PMID: 29417306 No abstract available.
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, Schirbel A, Deutschbein T, Williams TA, Rhayem Y, Quinkler M, Rayes N, Monticone S, Wild V, Gomez-Sanchez CE, Reis AC, Petersenn S, Wester HJ, Kropf S, Fassnacht M, Lang K, Herrmann K, Buck AK, Bluemel C, Hahner S. Heinze B, et al. Among authors: petersenn s. Hypertension. 2018 Feb;71(2):317-325. doi: 10.1161/HYPERTENSIONAHA.117.09975. Epub 2017 Dec 26. Hypertension. 2018. PMID: 29279316 Free article.
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.
Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J; Pasireotide G2304 Study Group. Lacroix A, et al. Among authors: petersenn s. Lancet Diabetes Endocrinol. 2018 Jan;6(1):17-26. doi: 10.1016/S2213-8587(17)30326-1. Epub 2017 Oct 12. Lancet Diabetes Endocrinol. 2018. PMID: 29032078 Clinical Trial.
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, Lanza V, Söderkvist P, Stenman A, Larsson C, Svahn F, Chen JL, Marquard J, Fraenkel M, Walter MA, Peczkowska M, Prejbisz A, Jarzab B, Hasse-Lazar K, Petersenn S, Moeller LC, Meyer A, Reisch N, Trupka A, Brase C, Galiano M, Preuss SF, Kwok P, Lendvai N, Berisha G, Makay Ö, Boedeker CC, Weryha G, Racz K, Januszewicz A, Walz MK, Gimm O, Opocher G, Eng C, Neumann HPH; European-American-Asian Pheochromocytoma-Paraganglioma Registry Study Group. Bausch B, et al. Among authors: petersenn s. JAMA Oncol. 2017 Sep 1;3(9):1204-1212. doi: 10.1001/jamaoncol.2017.0223. JAMA Oncol. 2017. PMID: 28384794 Free PMC article.
Erratum: Histological criteria for atypical pituitary adenomas--data from the German pituitary adenoma registry suggests modifications.
Miermeister CP, Petersenn S, Buchfelder M, Fahlbusch R, Lüdecke DK, Hölsken A, Bergmann M, Knappe UJ, Hans VH, Flitsch J, Saeger W, Buslei R. Miermeister CP, et al. Among authors: petersenn s. Acta Neuropathol Commun. 2016 Feb 29;4:21. doi: 10.1186/s40478-016-0290-y. Acta Neuropathol Commun. 2016. PMID: 26984397 Free PMC article.
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.
Miermeister CP, Petersenn S, Buchfelder M, Fahlbusch R, Lüdecke DK, Hölsken A, Bergmann M, Knappe HU, Hans VH, Flitsch J, Saeger W, Buslei R. Miermeister CP, et al. Among authors: petersenn s. Acta Neuropathol Commun. 2015 Aug 19;3:50. doi: 10.1186/s40478-015-0229-8. Acta Neuropathol Commun. 2015. PMID: 26285571 Free PMC article.
Diagnosis of Primary Hypophysitis in Germany.
Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S; Pituitary Working Group of the German Society of Endocrinology. Honegger J, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2015 Oct;100(10):3841-9. doi: 10.1210/jc.2015-2152. Epub 2015 Aug 11. J Clin Endocrinol Metab. 2015. PMID: 26262437
Treatment of Primary Hypophysitis in Germany.
Honegger J, Buchfelder M, Schlaffer S, Droste M, Werner S, Strasburger C, Störmann S, Schopohl J, Kacheva S, Deutschbein T, Stalla G, Flitsch J, Milian M, Petersenn S, Elbelt U; Pituitary Working Group of the German Society of Endocrinology. Honegger J, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2015 Sep;100(9):3460-9. doi: 10.1210/jc.2015-2146. Epub 2015 Jun 19. J Clin Endocrinol Metab. 2015. PMID: 26091204
Cushing disease: where do we stand, where are we heading?
Fleseriu M, Petersenn S. Fleseriu M, et al. Among authors: petersenn s. Pituitary. 2015 Apr;18(2):179-80. doi: 10.1007/s11102-015-0647-4. Pituitary. 2015. PMID: 25759331 No abstract available.
Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.
Petersenn S, Beckers A, Ferone D, van der Lely A, Bollerslev J, Boscaro M, Brue T, Bruzzi P, Casanueva FF, Chanson P, Colao A, Reincke M, Stalla G, Tsagarakis S. Petersenn S, et al. Eur J Endocrinol. 2015 Jun;172(6):R227-39. doi: 10.1530/EJE-14-0883. Epub 2015 Jan 19. Eur J Endocrinol. 2015. PMID: 25599709 Review.
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.
Schopohl J, Gu F, Rubens R, Van Gaal L, Bertherat J, Ligueros-Saylan M, Trovato A, Hughes G, Salgado LR, Boscaro M, Pivonello R; Pasireotide B2305 Study Group. Schopohl J, et al. Pituitary. 2015 Oct;18(5):604-12. doi: 10.1007/s11102-014-0618-1. Pituitary. 2015. PMID: 25537481 Free PMC article. Clinical Trial.
Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice.
Giustina A, Bevan J, Bronstein M, Casanueva F, Chanson P, Petersenn S, Truong TX, Massien C, Dias-Barbosa C, Guillemin I, Arnould B, Melmed S. Giustina A, et al. Among authors: petersenn s. Value Health. 2014 Nov;17(7):A355. doi: 10.1016/j.jval.2014.08.754. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200705 Free article. No abstract available.
Expression analysis of GADD45γ, MEG3, and p8 in pituitary adenomas.
Binse I, Ueberberg B, Sandalcioglu IE, Flitsch J, Luedecke DK, Mann K, Petersenn S. Binse I, et al. Among authors: petersenn s. Horm Metab Res. 2014 Aug;46(9):644-50. doi: 10.1055/s-0034-1383566. Epub 2014 Aug 15. Horm Metab Res. 2014. PMID: 25126861
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.
Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM; Pasireotide B2305 Study Group. Pivonello R, et al. Among authors: petersenn s. Clin Endocrinol (Oxf). 2014 Sep;81(3):408-17. doi: 10.1111/cen.12431. Epub 2014 Mar 27. Clin Endocrinol (Oxf). 2014. PMID: 24533697 Clinical Trial.
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial.
Caron PJ, Bevan JS, Petersenn S, Flanagan D, Tabarin A, Prévost G, Maisonobe P, Clermont A; PRIMARYS Investigators. Caron PJ, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2014 Apr;99(4):1282-90. doi: 10.1210/jc.2013-3318. Epub 2013 Jan 1. J Clin Endocrinol Metab. 2014. PMID: 24423301 Free PMC article. Clinical Trial.
Cardiac risk in patients with treatment naïve, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general population.
Berg C, Petersenn S, Walensi M, Möhlenkamp S, Bauer M, Lehmann N, Roggenbuck U, Moebus S, Broecker-Preuss M, Sandalcioglu IE, Stolke D, Sure U, Joeckel KH, Erbel R, Führer D, Mann K; Investigative Group of the Heinz Nixdorf Recall Study. Berg C, et al. Among authors: petersenn s. Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):125-32. doi: 10.1055/s-0032-1314811. Epub 2013 Jan 21. Exp Clin Endocrinol Diabetes. 2013. PMID: 23338744
Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group. Fassnacht M, et al. N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551107 Free article. Clinical Trial.
A 12-month phase 3 study of pasireotide in Cushing's disease.
Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM; Pasireotide B2305 Study Group. Colao A, et al. Among authors: petersenn s. N Engl J Med. 2012 Mar 8;366(10):914-24. doi: 10.1056/NEJMoa1105743. N Engl J Med. 2012. PMID: 22397653 Free article. Clinical Trial.
Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR.
Schopohl J, Strasburger CJ, Caird D, Badenhoop K, Beuschlein F, Droste M, Plöckinger U, Petersenn S; German Lanreotide Study Group. Schopohl J, et al. Among authors: petersenn s. Exp Clin Endocrinol Diabetes. 2011 Mar;119(3):156-62. doi: 10.1055/s-0030-1267244. Epub 2010 Nov 17. Exp Clin Endocrinol Diabetes. 2011. PMID: 21086246 Clinical Trial.
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
Fassnacht M, Johanssen S, Fenske W, Weismann D, Agha A, Beuschlein F, Führer D, Jurowich C, Quinkler M, Petersenn S, Spahn M, Hahner S, Allolio B; German ACC Registry Group. Fassnacht M, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2010 Nov;95(11):4925-32. doi: 10.1210/jc.2010-0803. Epub 2010 Jul 28. J Clin Endocrinol Metab. 2010. PMID: 20668036
The rational use of pituitary stimulation tests.
Petersenn S, Quabbe HJ, Schöfl C, Stalla GK, von Werder K, Buchfelder M. Petersenn S, et al. Dtsch Arztebl Int. 2010 Jun;107(25):437-43. doi: 10.3238/arztebl.2010.0437. Epub 2010 Jun 25. Dtsch Arztebl Int. 2010. PMID: 20644702 Free PMC article. Review.
Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.
Berg C, Petersenn S, Lahner H, Herrmann BL, Buchfelder M, Droste M, Stalla GK, Strasburger CJ, Roggenbuck U, Lehmann N, Moebus S, Jöckel KH, Möhlenkamp S, Erbel R, Saller B, Mann K; Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigators. Berg C, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2010 Aug;95(8):3648-56. doi: 10.1210/jc.2009-2570. Epub 2010 May 12. J Clin Endocrinol Metab. 2010. PMID: 20463098
Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors.
Müssig K, Oksüz MO, Dudziak K, Ueberberg B, Wehrmann M, Horger M, Schulz S, Häring HU, Pfannenberg C, Bares R, Gallwitz B, Petersenn S. Müssig K, et al. Among authors: petersenn s. Horm Metab Res. 2010 Jul;42(8):599-606. doi: 10.1055/s-0030-1253354. Epub 2010 Apr 26. Horm Metab Res. 2010. PMID: 20422506
Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial.
Petersenn S, Schopohl J, Barkan A, Mohideen P, Colao A, Abs R, Buchelt A, Ho YY, Hu K, Farrall AJ, Melmed S, Biller BM; Pasireotide Acromegaly Study Group. Petersenn S, et al. J Clin Endocrinol Metab. 2010 Jun;95(6):2781-9. doi: 10.1210/jc.2009-2272. Epub 2010 Apr 21. J Clin Endocrinol Metab. 2010. PMID: 20410233 Clinical Trial.
[Arterial hypertension and subclinical Cushing's syndrome].
Fassnacht M, Beuschlein F, Quinkler M, Petersenn S. Fassnacht M, et al. Among authors: petersenn s. MMW Fortschr Med. 2010 Feb 18;152(7):39-41. MMW Fortschr Med. 2010. PMID: 20364508 German. No abstract available.
[Pheochromocytoma: current diagnostics and treatment].
Quinkler M, Fassnacht M, Petersenn S, Reisch N, Willenberg HS, Diederich S. Quinkler M, et al. Among authors: petersenn s. MMW Fortschr Med. 2010 Feb 18;152(7):36-8. MMW Fortschr Med. 2010. PMID: 20364507 German. No abstract available.
Rationale for treatment and therapeutic options in Cushing's disease.
Stewart PM, Petersenn S. Stewart PM, et al. Among authors: petersenn s. Best Pract Res Clin Endocrinol Metab. 2009 Dec;23 Suppl 1:S15-22. doi: 10.1016/S1521-690X(09)70004-1. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 20129190 Review.
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.
Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Müssig K, Muresan M, Schäffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plöckinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP; European-American Pheochromocytoma Study Group. Erlic Z, et al. Among authors: petersenn s. Clin Cancer Res. 2009 Oct 15;15(20):6378-85. doi: 10.1158/1078-0432.CCR-09-1237. Epub 2009 Oct 13. Clin Cancer Res. 2009. PMID: 19825962 Free article.
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.
Ziegler CG, Brown JW, Schally AV, Erler A, Gebauer L, Treszl A, Young L, Fishman LM, Engel JB, Willenberg HS, Petersenn S, Eisenhofer G, Ehrhart-Bornstein M, Bornstein SR. Ziegler CG, et al. Among authors: petersenn s. Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15879-84. doi: 10.1073/pnas.0907843106. Epub 2009 Aug 27. Proc Natl Acad Sci U S A. 2009. PMID: 19717419 Free PMC article.
Expression of ghrelin and its receptor in human tissues.
Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S. Ueberberg B, et al. Among authors: petersenn s. Horm Metab Res. 2009 Nov;41(11):814-21. doi: 10.1055/s-0029-1233462. Epub 2009 Aug 10. Horm Metab Res. 2009. PMID: 19670151
Saliva as a medium for aldosterone measurement in repeated sampling studies.
Manolopoulou J, Mulatero P, Maser-Gluth C, Rossignol P, Spyroglou A, Vakrilova Y, Petersenn S, Zwermann O, Plouin PF, Reincke M, Bidlingmaier M. Manolopoulou J, et al. Among authors: petersenn s. Steroids. 2009 Oct;74(10-11):853-8. doi: 10.1016/j.steroids.2009.05.006. Epub 2009 May 27. Steroids. 2009. PMID: 19481102
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.
Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J. Boscaro M, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2009 Jan;94(1):115-22. doi: 10.1210/jc.2008-1008. Epub 2008 Oct 28. J Clin Endocrinol Metab. 2009. PMID: 18957506 Clinical Trial.
Lipodystrophy in patients with acromegaly receiving pegvisomant.
Bonert VS, Kennedy L, Petersenn S, Barkan A, Carmichael J, Melmed S. Bonert VS, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2008 Sep;93(9):3515-8. doi: 10.1210/jc.2008-0833. Epub 2008 Jul 8. J Clin Endocrinol Metab. 2008. PMID: 18611977
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.
Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M. Biller BM, et al. Among authors: petersenn s. J Clin Endocrinol Metab. 2008 Jul;93(7):2454-62. doi: 10.1210/jc.2007-2734. Epub 2008 Apr 15. J Clin Endocrinol Metab. 2008. PMID: 18413427 Free PMC article. Review.
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.
Mercado M, Borges F, Bouterfa H, Chang TC, Chervin A, Farrall AJ, Patocs A, Petersenn S, Podoba J, Safari M, Wardlaw J; SMS995B2401 Study Group. Mercado M, et al. Among authors: petersenn s. Clin Endocrinol (Oxf). 2007 Jun;66(6):859-68. doi: 10.1111/j.1365-2265.2007.02825.x. Epub 2007 Apr 25. Clin Endocrinol (Oxf). 2007. PMID: 17465997 Free PMC article. Clinical Trial.
[Leydig cell tumor as a cause of hirsutism in a postmenopausal woman].
Matuszczyk A, Petersenn S, Lahner H, Haude M, Veit P, Becker JU, Kimmig R, Bockisch A, Mann K. Matuszczyk A, et al. Among authors: petersenn s. Med Klin (Munich). 2007 Mar 15;102(3):259-62. doi: 10.1007/s00063-007-1032-5. Med Klin (Munich). 2007. PMID: 17345023 German.
[Diagnosis and therapy of endocrine hypertension].
Unger N, Petersenn S, Mann K. Unger N, et al. Among authors: petersenn s. Med Klin (Munich). 2006 Mar 22;101 Suppl 1:170-2. Med Klin (Munich). 2006. PMID: 16802547 German.
Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery.
Fasshauer M, Lincke T, Witzigmann H, Kluge R, Tannapfel A, Moche M, Buchfelder M, Petersenn S, Kratzsch J, Paschke R, Koch CA. Fasshauer M, et al. Among authors: petersenn s. BMC Cancer. 2006 Apr 27;6:108. doi: 10.1186/1471-2407-6-108. BMC Cancer. 2006. PMID: 16643652 Free PMC article.
Endoscopic treatment of large primary adrenal tumours.
Walz MK, Petersenn S, Koch JA, Mann K, Neumann HP, Schmid KW. Walz MK, et al. Among authors: petersenn s. Br J Surg. 2005 Jun;92(6):719-23. doi: 10.1002/bjs.4964. Br J Surg. 2005. PMID: 15856491